Junxiao Hu, MS
Assistant Professor, Pediatrics-Endocrinology

Publications

  • Kolb JM, Hu J, DeSanto K, Gao D, Singh S, Imperiale T, Lieberman DA, Boland CR, Patel SG. Early-Age Onset Colorectal Neoplasia in Average-Risk Individuals Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis. Gastroenterology. 2021 Oct;161(4):1145-1155.e12. PubMed PMID: 34119517
  • Goldstein NB, Steel A, Barbulescu CC, Koster MI, Wright MJ, Jones KL, Gao B, Ward B, Woessner B, Trottier Z, Pakieser J, Hu J, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 Signaling. J Invest Dermatol. 2021 Mar;141(3):638-647.e13. PubMed PMID: 32800877
  • Duarte C, Beuselinck B, Weise N, Dizman N, Collier K, Li H, Martinez Chanza N, Elias R, Rose TL, Brugarolas J, Agarwal N. Treatment outcomes in renal cell carcinoma patients with metastases to the pancreas and other sites.
  • Lentz RW, Friedrich T, Hu J, Leal AD, Kim SS, Davis SL, Purcell T, Messersmith WA, Lieu CH. Tissue tumor mutational burden (TMB) as a biomarker of efficacy with immune checkpoint inhibitors (ICI) in metastatic gastrointestinal (mGI) cancers.
  • Friedrich T, Hu J, Lentz RW, Leal AD, Kim SS, Messersmith WA, Davis SL, McCarter M, Ahrendt SA, Gleisner A, Lieu CH. Utility of chemotherapy given before and/or after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal adenocarcinoma with peritoneal metastases.
  • Jordan K, Sikora MJ, Slansky JE, Minic A, Richer JK, Moroney MR, Hu J, Wolsky RJ, Watson ZL, Yamamoto TM, Costello JC, Clauset A, Behbakht K, Kumar TR, Bitler BG. The capacity of the ovarian cancer tumor microenvironment to integrate inflammation signaling conveys a shorter disease-free interval. Clin Cancer Res. 2020 Sep 14. [Epub ahead of print] PubMed PMID: 32928797
  • Goldstein NB, Steel A, Barbulescu CC, Koster MI, Wright MJ, Jones KL, Gao B, Ward B, Woessner B, Trottier Z, Pakieser J, Hu J, Lambert KA, Shellman YG, Fujita M, Robinson WA, Roop DR, Norris DA, Birlea SA. MELANOCYTE PRECURSORS IN THE HAIR FOLLICLE BULGE OF REPIGMENTED VITILIGO SKIN ARE CONTROLLED BY RHO-GTPase, KCTD10 AND CTNNB1 SIGNALING. J Invest Dermatol. 2020 Aug 12. [Epub ahead of print] PubMed PMID: 32800877
  • Patel SG, Ahnen DJ, Gumidyala A, Espinoza J, Nicklawsky A, Hu J, Smith D, Lowery J, Austin G, Cockburn M. Poor Knowledge of Personal and Familial Colorectal Cancer Risk and Screening Recommendations Associated with Advanced Colorectal Polyps. Dig Dis Sci. 2020 Sep;65(9):2542-2550. PubMed PMID: 32144601
  • Borges VF, Hu J, Young C, Maggard J, Parris HJ, Gao D, Lyons TR. Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer. NPJ Breast Cancer. 2020;6:56. PubMed PMID: 33088913
  • Hu J, Blatchford PJ, Goldenberg NA, Kittelson JM. Group sequential designs for clinical trials with bivariate endpoints. Stat Med. 2020 Nov 20;39(26):3823-3839. PubMed PMID: 33048360
  • Borges VF, Hu J, Young C, Maggard J, Parris HJ, Gao D, Lyons TR. Semaphorin 7a is a biomarker for recurrence in postpartum breast cancer. NPJ Breast Cancer. 2020;6:56. PubMed PMID: 33088913
  • Hu J, Blatchford PJ, Goldenberg NA, Kittelson JM. Group sequential designs for clinical trials with bivariate endpoints. Stat Med. 2020 Nov 20;39(26):3823-3839. PubMed PMID: 33048360
  • Jordan KR, Sikora MJ, Slansky JE, Minic A, Richer JK, Moroney MR, Hu J, Wolsky RJ, Watson ZL, Yamamoto TM, Costello JC, Clauset A, Behbakht K, Kumar TR, Bitler BG. The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval. Clin Cancer Res. 2020 Dec 1;26(23):6362-6373. PubMed PMID: 32928797
  • Patel SG, Ahnen DJ, Gumidyala A, Espinoza J, Nicklawsky A, Hu J, Smith D, Lowery J, Austin G, Cockburn M. Poor Knowledge of Personal and Familial Colorectal Cancer Risk and Screening Recommendations Associated with Advanced Colorectal Polyps. Dig Dis Sci. 2020 Sep;65(9):2542-2550. PubMed PMID: 32144601
  • Duarte C, Martinez Chanza N, Collier K, Dizman N, Rathi N, McKay RR, Panian J, Narayan V, Carneiro BA, Mega AE, Hu J. Outcomes of patients with pancreatic-only oligometastatic renal cell carcinoma (RCC).
  • Patil T, Nie Y, Hu J, Schenk EL, Pacheco JM, Purcell WT, Bunn PA, Camidge DR. Duration of pemetrexed maintenance therapy with or without pembrolizumab is associated with risk of renal toxicity in patients with metastatic nonsquamous NSCLC.
  • Kessler ER, Hu J, Srivastava G, Kemme DJ, Iruku P, Rana V, Schuster SR, Amirault M, Callihan E, Flaig TW, Lam ET. Phase I/II trial of pembrolizumab and cabozantinib in the treatment of metastatic renal cell carcinoma (mRCC).
View All (17 Total) View Less

General Information

Department: Pediatrics-Endocrinology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile
;